Trials / Not Yet Recruiting
Not Yet RecruitingNCT06922578
Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 4 Years – 9 Years
- Healthy volunteers
- Accepted
Summary
The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis. The main question it aims to answer is: Will Neoputty MTA pulpotomy have higher clinical and radiographic success in comparison to Endoflas pulpectomy in primary molars with irreversible pulpitis?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | NeoPUTTY MTA pulpotomy | Neoputty MTA pulpotomy performed in vital primary molars with symptomatic irreversible pulpitis |
| PROCEDURE | Endoflas pulpectomy | Endoflas pulpectomy in vital primary molars with symptomatic irreversible pulpitis |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-05-01
- Completion
- 2026-06-01
- First posted
- 2025-04-10
- Last updated
- 2025-04-10
Source: ClinicalTrials.gov record NCT06922578. Inclusion in this directory is not an endorsement.